Danielle Middleton | Director, Safety Physician
Jazz Pharmaceuticals

Dr Danielle Middleton is an experienced physician having spent over a decade working within the National Health Service (NHS) in the UK, and within drug safety in the pharmaceutical industry. With a strong foundation in clinical practice, Danielle has dedicated the last few years to ensuring the safety and efficacy of medicines and medical devices used in the healthcare ecosystem. Over the course of her career, Danielle has acquired a unique blend of clinical, regulatory and pharmaceutical industry experience. After 10 years serving patients and gaining valuable insights into healthcare delivery within the NHS, Danielle transitioned to the pharmaceutical sector. Danielle has held roles contributing to the development and monitoring of both drug and medical device safety, at AstraZeneca and most recently at Jazz Pharmaceuticals. In addition to her industry experience, Danielle also held the role of Deputy Director of Benefit-Risk Evaluation within the Safety and Surveillance function of the UK Medicine and Healthcare products Regulatory Agency (MHRA), further enhancing her experience of regulatory affairs and compliance. Danielle is passionate about improving patient outcomes and committed to enhancing the field of pharmacovigilance through innovative practices and collaborative efforts.